Back
  1. Home
  2. Profile of Raphaël Peiffer (ULiège)
Profil

Peiffer Raphaël

GIGA Cancer - Metastases Research Laboratory

Département des sciences biomédicales et précliniques > GIGA

Département des sciences biomédicales et précliniques

See author's contact details
ORCID
0000-0001-5839-8849
Main Referenced Co-authors
Peulen, Olivier  (26)
Bellahcene, Akeila  (24)
Agirman, Ferman  (20)
Maloujahmoum, Naïma  (20)
Anania, Sandy  (16)
Main Referenced Keywords
Myoferlin (13); PDAC (5); CAF (4); mitochondria (4); pancreas (4);
Main Referenced Unit & Research Centers
d‐BRU - Dental Biomaterials Research Unit - ULiège [BE] (15)
Giga-Cancer - ULiège [BE] (7)
GIGA-LRM - GIGA Cancer-Metastases Research Laboratory - ULiège [BE] (5)
CIRM - Centre Interdisciplinaire de Recherche sur le Médicament - ULiège [BE] (2)
GIGA-LCTB - GIGA Cancer-Connective Tissue Biology - ULiège [BE] (1)
Main Referenced Disciplines
Oncology (22)
Biochemistry, biophysics & molecular biology (5)
Human health sciences: Multidisciplinary, general & others (2)
Gastroenterology & hepatology (1)
Laboratory medicine & medical technology (1)

Publications (total 26)

The most downloaded
881 downloads
Rademaker, G.* , Boumahd, Y.* , Peiffer, R., Anania, S., Wissocq, T., Liégeois, M., Luis, G., Sounni, N. E., Agirman, F., Maloujahmoum, N., De Tullio, P., Thiry, M., Bellahcene, A., Castronovo, V., & Peulen, O. (July 2022). Myoferlin targeting triggers mitophagy and primes ferroptosis in pancreatic cancer cells. Redox Biology, 53, 102324. doi:10.1016/j.redox.2022.102324 https://hdl.handle.net/2268/289926

The most cited

38 citations (Scopus®)

Rademaker, G., Hennequière, V., Nokin, M.-J., LOVINFOSSE, P., Durieux, F., GOFFLOT, S., Bellier, J., Costanza, B., Herfs, M., Peiffer, R., Bettendorff, L., Deroanne, C., Thiry, M., Delvenne, P., Hustinx, R., Bellahcene, A., Castronovo, V., & Peulen, O. (April 2018). Myoferlin controls mitochondrial structure and activity in pancreatic ductal adenocarcinoma, and affects tumor aggressiveness. Oncogene, 37 ((32)), 4398-4412. doi:10.1038/s41388-018-0287-z https://hdl.handle.net/2268/224119

Anania, S., Farnir, M., Peiffer, R., Boumahd, Y., Thiry, M., Agirman, F., Maloujahmoum, N., Bellahcene, A., & Peulen, O. (17 February 2024). Identification of myoferlin as a mitochondria-associated membranes component required for calcium signaling in PDAC cell lines. Cell Communication and Signaling, 22 (1), 133. doi:10.1186/s12964-024-01514-z
Peer reviewed

Boumahd, Y., Colin, G., Peiffer, R., Gullo, C., Agirman, F., Maloujahmoum, N., Coucke, P., Bellahcene, A., & Peulen, O. (04 September 2023). Modulation of radiosensitivity by myoferlin pharmacological targeting in human pancreatic cancer cell lines [Poster presentation]. GIGA day 2023, Liège, Belgium.

Cremer, J., Brohée, L., Dupont, L., Lefevre, C., Peiffer, R., Saarinen, A. M., Peulen, O., Bindels, L., Liu, J., Colige, A., & Deroanne, C. (11 July 2023). Acidosis-induced regulation of adipocyte G0S2 promotes crosstalk between adipocytes and breast cancer cells as well as tumor progression. Cancer Letters, 569, 216306. doi:10.1016/j.canlet.2023.216306
Peer Reviewed verified by ORBi

Crake, R., Gasmi, I., Dehaye, J., Lardinois, F., Peiffer, R., Maloujahmoum, N., Agirman, F., KOOPMANSCH, B., D’Haene, N., Azurmendi Senar, O., Arsenijevic, T., Lambert, F., Peulen, O., Van Laethem, J.-L., & Bellahcene, A. (17 May 2023). Resistance to Gemcitabine in Pancreatic Cancer Is Connected to Methylglyoxal Stress and Heat Shock Response. Cells, 12 (10), 1414. doi:10.3390/cells12101414
Peer Reviewed verified by ORBi

Peiffer, R., Boumahd, Y., Gullo, C., Agirman, F., Maloujahmoum, N., Masamune, A., Letellier Elisabeth, Bellahcene, A., & Peulen, O. (03 May 2023). Myoferlin, a new drug target in pancreatic CAFs, promotes desmoplasia and tumor aggressiveness [Poster presentation]. Gordon Research Conference - Pancreatic Diseases, Lucca, Italy.

Bruyere, D., RONCARATI, P., Lebeau, A., Lerho, T., Poulain, F., Hendrick, E., Pilard, C., Reynders, C., Ancion, M., Luyckx, M., Renard, M., Jacob, Y., Twizere, J.-C., Peiffer, R., Peulen, O., Delvenne, P., Hubert, P., McBride, A., Gillet, N., ... Herfs, M. (2023). Human papillomavirus E6/E7 oncoproteins promote radiotherapy-mediated tumor suppression by globally hijacking host DNA damage repair. Theranostics, 13 (3), 1130 - 1149. doi:10.7150/thno.78091
Peer Reviewed verified by ORBi

Peiffer, R., Boumahd, Y., Gullo, C., Crake, R., Letellier, E., Bellahcene, A., & Peulen, O. (22 December 2022). Cancer-Associated Fibroblast Diversity Shapes Tumor Metabolism in Pancreatic Cancer. Cancers, 15 (1), 61. doi:10.3390/cancers15010061
Peer Reviewed verified by ORBi

Boumahd, Y., Rademaker, G., Peiffer, R., Anania, S., Gullo, C., Agirman, F., Maloujahmoum, N., Bellahcene, A., & Peulen, O. (30 September 2022). Myoferlin targeting triggers mitophagy and primes ferroptosis in pancreatic cancer cells. Investigation of STAT3 involvement [Poster presentation]. BACR 2022, Gand, Belgium.

Peiffer, R., Boumahd, Y., Anania, S., Gullo, C., Agirman, F., Maloujahmoum, N., Masamune Atsushi, Letellier Elisabeth, Bellahcene, A., & Peulen, O. (30 September 2022). The role of myoferlin in PDAC fibroblasts and desmoplasia [Poster presentation]. BACR - annual meeting 2022, Ghent, Belgium.

Peiffer, R., Boumahd, Y., Anania, S., Gullo, C., Agirman, F., Maloujahmoum, N., Asamune, A., Letellier, E., Bellahcene, A., & Peulen, O. (06 September 2022). The role of myoferlin in pancreatic cancer fibroblasts and desmoplasia [Poster presentation]. GIGA Day 2022, Liège, Belgium.

Rademaker, G.* , Boumahd, Y.* , Peiffer, R., Anania, S., Wissocq, T., Liégeois, M., Luis, G., Sounni, N. E., Agirman, F., Maloujahmoum, N., De Tullio, P., Thiry, M., Bellahcene, A., Castronovo, V., & Peulen, O. (July 2022). Myoferlin targeting triggers mitophagy and primes ferroptosis in pancreatic cancer cells. Redox Biology, 53, 102324. doi:10.1016/j.redox.2022.102324
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Boumahd, Y., Rademaker, G., Peiffer, R., Anania, S., Agirman, F., Maloujahmoum, N., Bellahcene, A., & Peulen, O. (22 June 2022). Myoferlin targeting triggers mitophagy and primes ferroptosis in pancreatic cancer cells [Poster presentation]. EACR 2022.
Peer reviewed

Peiffer, R., Anania, S., Boumahd, Y., Agirman, F., Maloujahmoum, N., Masamune, A., Letellier, E., Bellahcene, A., & Peulen, O. (June 2022). The oncoprotein myoferlin as potential new participant in myCAF activity in pancreatic cancer [Poster presentation]. EACR 2022, Sevilla, Spain.

Rademaker, G., Costanza, B., Pyr Dit Ruys, S., Peiffer, R., Agirman, F., Maloujahmoum, N., Vertommen, D., Turtoi, A., Bellahcene, A., Castronovo, V.* , & Peulen, O.*. (2022). Paladin, overexpressed in colon cancer, is required for actin polymerisation and liver metastasis dissemination. Oncogenesis, 11, 42. doi:10.1038/s41389-022-00416-4
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Gullo, C., Boumahd, Y., Peiffer, R., Anania, S., Agirman, F., Maloujahmoum, N., Thiry, M., Bellahcene, A., & Peulen, O. (2022). Myoferlin controls beta actin cytoskeleton integrity in pancreas cancer [Paper presentation]. GIGA Day 2022, Liège, Belgium.

Boumahd, Y., Rademaker, G., Peiffer, R., Anania, S., Gullo, C., Agirman, F., Maloujahmoum, N., Bellahcene, A., & Peulen, O. (2022). Myoferlin targeting triggers mitophagy and primes ferroptosis in pancreatic cancer cells. Investigation on the involvement of STAT3 [Paper presentation]. GIGA Day 2022, Liège, Belgium.

Boumahd, Y., Rademaker, G., Peiffer, R., Anania, S., Maloujahmoum, N., Agirman, F., Bellahcene, A., & Peulen, O. (14 December 2021). Myoferlin targeting primes ferroptosis in pancreatic cancer cells [Poster presentation]. GIGA cancer day.

Peiffer, R., Anania, S., Boumahd, Y., Agirman, F., Maloujahmoum, N., Bossicard, Y., Masamune, A., Letellier, E., Bellahcene, A., & Peulen, O. (December 2021). Deciphering the role of myoferlin in pancreatic stellate cells, key players in the pancreatic tumor microenvironment [Poster presentation]. GIGA-Cancer day 2021, Liège, Belgium.

Peiffer, R., Anania, S., Boumahd, Y., Agirman, F., Maloujahmoum, N., Bossicard, Y., Masamune, A., Letellier, E., Bellahcene, A., & Peulen, O. (June 2021). New insights on the role of myoferlin in pancreatic stellate cells, the key orchestrators of pancreatic tumor microenvironment [Poster presentation]. EACR 2021.

Anania, S., Boumahd, Y., Peiffer, R., Thiry, M., Hego, A., Maloujahmoum, N., Agirman, F., Bellahcene, A., & Peulen, O. (June 2021). Myoferlin, a promising therapeutic target in PDAC, is located in mitochondria-associated membranes [Poster presentation]. 27TH CONGRESS OF THE EUROPEAN ASSOCIATION FOR CANCER RESEARCH.

Anania, S., Peiffer, R., Rademaker, G., Hego, A., Thiry, M., Deldicque, L., Francaux, M., Maloujahmoum, N., Agirman, F., Bellahcene, A., Castronovo, V., & Peulen, O. (21 June 2020). Myoferlin is a yet unknown interactor of the mitochondrial dynamics’ machinery in pancreas cancer cells. Cancers, 12 (6), 1643. doi:10.3390/cancers12061643
Peer Reviewed verified by ORBi

Anania, S., Rademaker, G., Peiffer, R., Hego, A., Deldicque, L., Maloujahmoum, N., Agirman, F., Bellahcene, A., Castronovo, V., & Peulen, O. (February 2020). Role of myoferlin in mitochondrial dynamics and metabolic fitness of pancreas cancer [Poster presentation]. BACR Annual Meeting 2020 - Cancer metastases: from bedside to bench, Brussels, Belgium.

Rademaker, G., Costanza, B., Bellier, J., Herfs, M., Peiffer, R., Agirman, F., Maloujahmoum, N., Habraken, Y., Delvenne, P., Bellahcene, A., Castronovo, V.* , & Peulen, O.*. (2019). Human colon cancer cells highly express myoferlin to maintain a fit mitochondrial network and escape p53-driven apoptosis. Oncogenesis. doi:10.1038/s41389-019-0130-6
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Rademaker, G., Hennequière, V., Nokin, M.-J., LOVINFOSSE, P., Durieux, F., GOFFLOT, S., Bellier, J., Costanza, B., Herfs, M., Peiffer, R., Bettendorff, L., Deroanne, C., Thiry, M., Delvenne, P., Hustinx, R., Bellahcene, A., Castronovo, V., & Peulen, O. (April 2018). Myoferlin controls mitochondrial structure and activity in pancreatic ductal adenocarcinoma, and affects tumor aggressiveness. Oncogene, 37 ((32)), 4398-4412. doi:10.1038/s41388-018-0287-z
Peer Reviewed verified by ORBi

Rademaker, G., Hennequière, V., Brohée, L., Nokin, M.-J., LOVINFOSSE, P., Durieux, F., GOFFLOT, S., Bellier, J., Costanza, B., Herfs, M., Peiffer, R., Anania, S., Bettendorff, L., Deroanne, C., Thiry, M., Delvenne, P., HUSTINX, R., Bellahcene, A., Castronovo, V., & Peulen, O. (2018). Myoferlin controls mitochondrial structure and activity in pancreatic cancer and affects tumor aggressiveness [Poster presentation]. Belgian Association for Cancer Research Congress.

Rademaker, G., Hennequière, V., Brohée, L., Nokin, M.-J., LOVINFOSSE, P., Durieux, F., GOFFLOT, S., Bellier, J., Costanza, B., Herfs, M., Peiffer, R., Bettendorff, L., Deroanne, C., Delvenne, P., Hustinx, R., Bellahcene, A., Castronovo, V., & Peulen, O. (22 September 2017). Myoferlin controls mitochondrial structure in pancreatic ductal adenocarcinoma, and affects tumor aggressiveness [Poster presentation]. Second U-CRC Symposium, Bruxelles, Belgium.

Contact ORBi